Definitive Healthcare Corp. (DH) stock
DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3067% below fair value
$1.31+0.06 (+4.80%)
Close on Nov 13, 2026Market cap $139.84MP/E –Yield –
Definitive Healthcare r&d expenses
Research and development expenses are spending on new products and technology.
Definitive Healthcare's R&D Expenses for the twelve months ending Sep 30, 2026 was $29.88M, down 11.6% year over year. For fiscal 2025 it was $34.78M, down 4.8% from the year before. The highest annual figure on record is $42.44M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.78M | -4.8% |
| FY2024 | Dec 31, 2024 | $36.52M | -14.0% |
| FY2023 | Dec 31, 2023 | $42.44M | +21.6% |
| FY2022 | Dec 31, 2022 | $34.89M | +87.9% |
| FY2021 | Dec 31, 2021 | $18.57M | +67.8% |
| FY2020 | Dec 31, 2020 | $11.06M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.67M | -11.7% |
| Q2 FY2026 | Jun 30, 2026 | $6.76M | -15.2% |
| Q1 FY2026 | Mar 31, 2026 | $6.50M | -30.1% |
| Q4 FY2025 | Dec 31, 2025 | $9.95M | +10.8% |
| Q3 FY2025 | Sep 30, 2025 | $7.55M | -62.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.97M | -31.1% |
| Q1 FY2025 | Mar 31, 2025 | $9.30M | -13.6% |
| Q4 FY2024 | Dec 31, 2024 | $8.98M | -12.2% |
| Q1 FY2024 | Jun 30, 2024 | $20.25M | +104.9% |
| Q4 FY2023 | Dec 31, 2023 | $11.57M | +14.2% |
| Q3 FY2023 | Sep 30, 2023 | $10.76M | +16.9% |
| Q2 FY2023 | Jun 30, 2023 | $10.23M | +17.5% |
| Q1 FY2023 | Mar 31, 2023 | $9.88M | +44.3% |
| Q4 FY2022 | Dec 31, 2022 | $10.13M | +76.2% |
| Q3 FY2022 | Sep 30, 2022 | $9.21M | +94.0% |
| Q2 FY2022 | Jun 30, 2022 | $8.71M | +103.6% |
| Q1 FY2022 | Mar 31, 2022 | $6.85M | +80.5% |
| Q4 FY2021 | Dec 31, 2021 | $5.75M | +64.4% |
| Q3 FY2021 | Sep 30, 2021 | $4.75M | +81.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.28M | +74.1% |
| Q1 FY2021 | Mar 31, 2021 | $3.79M | +52.3% |
| Q4 FY2020 | Dec 31, 2020 | $3.50M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.62M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.46M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.49M | – |
See a number that looks wrong?